24 research outputs found
Recommended from our members
A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR[superscript -/-] Mice
Background: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease and a risk
factor for cirrhosis, hepatocellular carcinoma and liver failure. Previously, we reported that dietary docosahexaenoic
acid (DHA, 22:6,n-3) was more effective than eicosapentaenoic acid (EPA, 20:5,n-3) at reversing western diet (WD)
induced NASH in LDLR-/- mice.
Methods: Using livers from our previous study, we carried out a global non-targeted metabolomic approach to
quantify diet-induced changes in hepatic metabolism.
Results: Livers from WD + olive oil (WD + O)-fed mice displayed histological and gene expression features
consistent with NASH. The metabolomic analysis of 320 metabolites established that the WD and n-3
polyunsaturated fatty acid (PUFA) supplementation had broad effects on all major metabolic pathways. Livers from
WD + O-fed mice were enriched in saturated (SFA) and monounsaturated fatty acids (MUFA), palmitoylsphingomyelin,
cholesterol, n-6 PUFA, n-6 PUFA-containing phosphoglycerolipids, n-6 PUFA-derived oxidized lipids
(12-HETE) and depleted of C20-22 n-3 PUFA-containing phosphoglycerolipids, C20-22 n-3 PUFA-derived oxidized lipids
(18-HEPE, 17,18-DiHETE) and S-lactoylglutathione, a methylglyoxal detoxification product. WD + DHA was more
effective than WD + EPA at attenuating WD + O-induced changes in NASH gene expression markers, n-6 PUFA and
oxidized lipids, citrate and S-lactosyl glutathione. Diet-induced changes in hepatic MUFA and sphingolipid content
were associated with changes in expression of enzymes involved in MUFA and sphingolipid synthesis. Changes in
hepatic oxidized fatty acids and S-lactoylglutathione, however, correlated with hepatic n-3 and n-6 C20-22 PUFA
content. Hepatic C20-22 n-3 PUFA content was inversely associated with hepatic α-tocopherol and ascorbate content
and positively associated with urinary F2- and F3-isoprostanes, revealing diet effects on whole body oxidative stress.
Conclusion: DHA regulation of hepatic SFA, MUFA, PUFA, sphingomyelin, PUFA-derived oxidized lipids and Slactoylglutathione
may explain the protective effects of DHA against WD-induced NASH in LDLR-/- mice
Extensive post-transcriptional regulation of microRNAs and its implications for cancer
MicroRNAs (miRNAs) are short, noncoding RNAs that post-transcriptionally regulate gene expression. While hundreds of mammalian miRNA genes have been identified, little is known about the pathways that regulate the production of active miRNA species. Here we show that a large fraction of miRNA genes are regulated post-transcriptionally. During early mouse development, many miRNA primary transcripts, including the Let-7 family, are present at high levels but are not processed by the enzyme Drosha. An analysis of gene expression in primary tumors indicates that the widespread down-regulation of miRNAs observed in cancer is due to a failure at the Drosha processing step. These data uncover a novel regulatory step in miRNA function and provide a mechanism for miRNA down-regulation in cancer
Recommended from our members
DepnerChristopherNutritionMetabolomicAnalysisOmega-3_SupportingInformation.zip
Background: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease and a risk
factor for cirrhosis, hepatocellular carcinoma and liver failure. Previously, we reported that dietary docosahexaenoic
acid (DHA, 22:6,n-3) was more effective than eicosapentaenoic acid (EPA, 20:5,n-3) at reversing western diet (WD)
induced NASH in LDLR-/- mice.
Methods: Using livers from our previous study, we carried out a global non-targeted metabolomic approach to
quantify diet-induced changes in hepatic metabolism.
Results: Livers from WD + olive oil (WD + O)-fed mice displayed histological and gene expression features
consistent with NASH. The metabolomic analysis of 320 metabolites established that the WD and n-3
polyunsaturated fatty acid (PUFA) supplementation had broad effects on all major metabolic pathways. Livers from
WD + O-fed mice were enriched in saturated (SFA) and monounsaturated fatty acids (MUFA), palmitoylsphingomyelin,
cholesterol, n-6 PUFA, n-6 PUFA-containing phosphoglycerolipids, n-6 PUFA-derived oxidized lipids
(12-HETE) and depleted of C20-22 n-3 PUFA-containing phosphoglycerolipids, C20-22 n-3 PUFA-derived oxidized lipids
(18-HEPE, 17,18-DiHETE) and S-lactoylglutathione, a methylglyoxal detoxification product. WD + DHA was more
effective than WD + EPA at attenuating WD + O-induced changes in NASH gene expression markers, n-6 PUFA and
oxidized lipids, citrate and S-lactosyl glutathione. Diet-induced changes in hepatic MUFA and sphingolipid content
were associated with changes in expression of enzymes involved in MUFA and sphingolipid synthesis. Changes in
hepatic oxidized fatty acids and S-lactoylglutathione, however, correlated with hepatic n-3 and n-6 C20-22 PUFA
content. Hepatic C20-22 n-3 PUFA content was inversely associated with hepatic α-tocopherol and ascorbate content
and positively associated with urinary F2- and F3-isoprostanes, revealing diet effects on whole body oxidative stress.
Conclusion: DHA regulation of hepatic SFA, MUFA, PUFA, sphingomyelin, PUFA-derived oxidized lipids and Slactoylglutathione
may explain the protective effects of DHA against WD-induced NASH in LDLR-/- mice
Recommended from our members
DepnerChristopherNutritionMetabolomicAnalysisOmega-3.pdf
Background: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease and a risk
factor for cirrhosis, hepatocellular carcinoma and liver failure. Previously, we reported that dietary docosahexaenoic
acid (DHA, 22:6,n-3) was more effective than eicosapentaenoic acid (EPA, 20:5,n-3) at reversing western diet (WD)
induced NASH in LDLR-/- mice.
Methods: Using livers from our previous study, we carried out a global non-targeted metabolomic approach to
quantify diet-induced changes in hepatic metabolism.
Results: Livers from WD + olive oil (WD + O)-fed mice displayed histological and gene expression features
consistent with NASH. The metabolomic analysis of 320 metabolites established that the WD and n-3
polyunsaturated fatty acid (PUFA) supplementation had broad effects on all major metabolic pathways. Livers from
WD + O-fed mice were enriched in saturated (SFA) and monounsaturated fatty acids (MUFA), palmitoylsphingomyelin,
cholesterol, n-6 PUFA, n-6 PUFA-containing phosphoglycerolipids, n-6 PUFA-derived oxidized lipids
(12-HETE) and depleted of C20-22 n-3 PUFA-containing phosphoglycerolipids, C20-22 n-3 PUFA-derived oxidized lipids
(18-HEPE, 17,18-DiHETE) and S-lactoylglutathione, a methylglyoxal detoxification product. WD + DHA was more
effective than WD + EPA at attenuating WD + O-induced changes in NASH gene expression markers, n-6 PUFA and
oxidized lipids, citrate and S-lactosyl glutathione. Diet-induced changes in hepatic MUFA and sphingolipid content
were associated with changes in expression of enzymes involved in MUFA and sphingolipid synthesis. Changes in
hepatic oxidized fatty acids and S-lactoylglutathione, however, correlated with hepatic n-3 and n-6 C20-22 PUFA
content. Hepatic C20-22 n-3 PUFA content was inversely associated with hepatic α-tocopherol and ascorbate content
and positively associated with urinary F2- and F3-isoprostanes, revealing diet effects on whole body oxidative stress.
Conclusion: DHA regulation of hepatic SFA, MUFA, PUFA, sphingomyelin, PUFA-derived oxidized lipids and Slactoylglutathione
may explain the protective effects of DHA against WD-induced NASH in LDLR-/- mice
Defects in Yolk Sac Vasculogenesis, Chorioallantoic Fusion, and Embryonic Axis Elongation in Mice with Targeted Disruption of Yap65
YAP is a multifunctional adapter protein and transcriptional coactivator with several binding partners well described in vitro and in cell culture. To explore in vivo requirements for YAP, we generated mice carrying a targeted disruption of the Yap gene. Homozygosity for the Yap(tm1Smil) allele (Yap(−/−)) caused developmental arrest around E8.5. Phenotypic characterization revealed a requirement for YAP in yolk sac vasculogenesis. Yolk sac endothelial and erythrocyte precursors were specified as shown by histology, PECAM1 immunostaining, and alpha globin expression. Nonetheless, development of an organized yolk sac vascular plexus failed in Yap(−/−) embryos. In striking contrast, vasculogenesis proceeded in both the allantois and the embryo proper. Mutant embryos showed patterned gene expression domains along the anteroposterior neuraxis, midline, and streak/tailbud. Despite this evidence of proper patterning and tissue specification, Yap(−/−) embryos showed developmental perturbations that included a notably shortened body axis, convoluted anterior neuroepithelium, caudal dysgenesis, and failure of chorioallantoic fusion. These results reveal a vital requirement for YAP in the developmental processes of yolk sac vasculogenesis, chorioallantoic attachment, and embryonic axis elongation
A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in <i>LDLR</i><sup><i>-/-</i></sup> Mice
<div><p>Background</p><p>Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease and a risk factor for cirrhosis, hepatocellular carcinoma and liver failure. Previously, we reported that dietary docosahexaenoic acid (DHA, 22:6,n-3) was more effective than eicosapentaenoic acid (EPA, 20:5,n-3) at reversing western diet (WD) induced NASH in LDLR<sup>-/-</sup> mice.</p> <p>Methods</p><p>Using livers from our previous study, we carried out a global non-targeted metabolomic approach to quantify diet-induced changes in hepatic metabolism. </p> <p>Results</p><p>Livers from WD + olive oil (WD + O)-fed mice displayed histological and gene expression features consistent with NASH. The metabolomic analysis of 320 metabolites established that the WD and n-3 polyunsaturated fatty acid (PUFA) supplementation had broad effects on all major metabolic pathways. Livers from WD + O-fed mice were enriched in saturated (SFA) and monounsaturated fatty acids (MUFA), palmitoyl-sphingomyelin, cholesterol, n-6 PUFA, n-6 PUFA-containing phosphoglycerolipids, n-6 PUFA-derived oxidized lipids (12-HETE) and depleted of C<sub>20-22</sub> n-3 PUFA-containing phosphoglycerolipids, C<sub>20-22</sub> n-3 PUFA-derived oxidized lipids (18-HEPE, 17,18-DiHETE) and S-lactoylglutathione, a methylglyoxal detoxification product. WD + DHA was more effective than WD + EPA at attenuating WD + O-induced changes in NASH gene expression markers, n-6 PUFA and oxidized lipids, citrate and S-lactosyl glutathione. Diet-induced changes in hepatic MUFA and sphingolipid content were associated with changes in expression of enzymes involved in MUFA and sphingolipid synthesis. Changes in hepatic oxidized fatty acids and S-lactoylglutathione, however, correlated with hepatic n-3 and n-6 C<sub>20-22</sub> PUFA content. Hepatic C<sub>20-22</sub> n-3 PUFA content was inversely associated with hepatic α-tocopherol and ascorbate content and positively associated with urinary F2- and F3-isoprostanes, revealing diet effects on whole body oxidative stress. </p> <p>Conclusion</p><p>DHA regulation of hepatic SFA, MUFA, PUFA, sphingomyelin, PUFA-derived oxidized lipids and S-lactoylglutathione may explain the protective effects of DHA against WD-induced NASH in LDLR<sup>-/-</sup> mice. </p> </div
Diet effects on hepatic markers of inflammation, SFA, MUFA and damage.
<p>Linear regression analysis of hepatic palmitoyl-sphingomyelin (Fold Change relative to chow) versus hepatic MCP1 mRNA expression (fold change relative to chow) (Panel A); hepatic total MUFA content (µmoles total MUFA/mg protein) (Panel B); hepatic palmitate (16:0) (µmoles /mg protein) (Panel C); and plasma AST (units (U)/ml of plasma) (Panel D). Palmitoyl-sphingomyelin was quantified in the metabolomic analysis while hepatic MCP1, MUFA, palmitate, and plasma AST were quantified and reported previously [8]. Each data point in Panels A-D represents the relative abundance of palmitoyl-sphingomyelin and hepatic MCP1 mRNA, MUFA, 16:0 or plasma AST for each animal. The groups are colored-coded to facilitate visualization of the distribution in each group.</p